Volume 30, Number 9—September 2024
CME ACTIVITY - Research
Clinical Aspects and Disease Severity of Streptococcus dysgalactiae Subspecies equisimilis Bacteremia, Finland1
Table 2
Characteristic | Total, n = 159 | Survivors, n = 150 | Nonsurvivors, n = 9 | p value |
---|---|---|---|---|
Admitted to intensive care unit |
11 (7) |
8 (5) |
3 (33) |
0.017 |
Needed mechanical ventilation | 3 (2) | 2 (1) | 1 (11) | 0.161 |
Needed continuous renal replacement therapy | 1 (1) | 1 (1) | 0 | NA |
Needed hemodialysis | 1 (1) | 1 (1) | 0 | NA |
Needed vasopressors |
15 (9) |
12 (8) |
3 (33) |
0.041 |
Lowered level of consciousness† | 37 (23) | 31 (21) | 6 (67) | 0.005 |
Unconscious |
7 (4) |
4 (3) |
3 (33) |
0.004 |
Hypotension‡ | 36 (23) | 30 (20) | 6 (67) | 0.005 |
Septic shock§ | 18 (11) | 13 (9) | 5 (56) | 0.001 |
Disseminated intravascular coagulation¶ | 6 (4) | 5 (3) | 1 (11) | 0.299 |
Multiorgan failure# |
12 (8) |
8 (5) |
4 (44) |
0.002 |
Underwent surgical intervention | 38 (24) | 33 (22) | 5 (56) | 0.037 |
*Values are no. (%) except as indicated; p values compare survivors and nonsurvivors. NA, not applicable. †Lowered level of consciousness (unconscious or confusion) >1 time during the first 2 days after positive blood culture. ‡Systolic blood pressure <90 mm Hg >1 time during days 0–2 after positive blood culture. §Use of vasopressor and blood lactate level >2 mmol/L >1 time during days 0–2 after positive blood culture. ¶Platelet counts <100 × 109/L. #Observed >3 concomitant organ failures.
1Preliminary results from this study were presented at the European Congress of Clinical Microbiology and Infectious Diseases; April 27–30, 2024; Barcelona, Spain.
Page created: July 02, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.